The ELEVATE Study shows that atogepant effectively prevents episodic migraine.

Published Date: 24 Apr 2023

Atogepant (Qulipta) performed better than a placebo in the ELEVATE study for preventing episodic migraine in patients who were resistant to other treatments.

Read Full News

Latest News

Novel, Adaptive DBS Tied to Fewer Falls in Parkinson’s

In a small feasibility study, a novel adaptive DBS system synchronized with the walking cycle has been shown to reduce the risk for falls among patients with Parkinson’s disease.

ECT Tied to Delayed Schizophrenia Rehospitalizations

Electroconvulsive therapy (ECT) is associated with longer time to hospital readmission or suicide compared to non-ECT treatment in patients with schizophrenia, a study shows.

Sleep Disorders May Raise Risk for Sudden Death in Epilepsy

Comorbid primary sleep disorders are tied to higher risk for sudden unexpected death, all-cause mortality, and accidents in patients with epilepsy, a new study finds.

Transcranial Stimulation Shows Promise for Teen Self-Injury

For adolescents with depression and nonsuicidal self-injury, high-intensity transcranial alternating current stimulation improved emotion regulation, reduced attention to self-injury cues, and eased depressive symptoms in a proof-of-concept trial.

Can Treating Prodromal MS Delay or Prevent Disease Onset?

Researchers are investigating whether treating prodromal symptoms that precede radiologically isolated syndrome can delay or prevent disease onset.

Difficulty Conceiving, Not IVF, Linked to Autism Risk

The findings highlight the need to better understand the causes of infertility rather than the treatments used to address it.

Todays Updates

Vistagen's Anxiety Disorder Drug Misses Main Goal in Late-stage Trial, Shares Plummet

Vistagen Therapeutics said on Tuesday its experimental anxiety disorder drug failed to meet the main goal of a late-stage ⁠trial testing its ability to reduce symptoms in...

Combined Models With AI Improve Breast Cancer Prediction

Combining mammography AI, polygenic, and clinical risk models improves 10-year breast cancer risk prediction compared with any single model.

Todays Updates

Vistagen's Anxiety Disorder Drug Misses Main Goal in Late-stage Trial, Shares Plummet

Vistagen Therapeutics said on Tuesday its experimental anxiety disorder drug failed to meet the main goal of a late-stage ⁠trial testing its ability to reduce symptoms in...

Combined Models With AI Improve Breast Cancer Prediction

Combining mammography AI, polygenic, and clinical risk models improves 10-year breast cancer risk prediction compared with any single model.

Latest News

In a small feasibility study, a novel adaptive DBS system synchronized with the walking cycle has been shown to reduce the risk for falls among patients with Parkinson’s disease.

Electroconvulsive therapy (ECT) is associated with longer time to hospital readmission or suicide compared to non-ECT treatment in patients with schizophrenia, a study shows.

Comorbid primary sleep disorders are tied to higher risk for sudden unexpected death, all-cause mortality, and accidents in patients with epilepsy, a new study finds.

For adolescents with depression and nonsuicidal self-injury, high-intensity transcranial alternating current stimulation improved emotion regulation, reduced attention to self-injury cues, and eased depressive symptoms in a proof-of-concept trial.

Researchers are investigating whether treating prodromal symptoms that precede radiologically isolated syndrome can delay or prevent disease onset.

The findings highlight the need to better understand the causes of infertility rather than the treatments used to address it.

News All Time

CMS Rule Misses Mark on CPAP Adherence

A Kaiser Permanente study shows some people who initially struggle with CPAP adherence still use the device at 1 year, suggesting CMS’ 90-day cutoff is too strict.

New Imaging Agent Could Speed Detection of AD-Related Tau

A novel PET imaging agent identified AD-related tau earlier and in more patients than the currently used tracer, possibly speeding AD detection, a new study shows.

Federally Funded Research Backs Tighter Drinking Limits

A federally funded review conducted to inform US dietary advice supports a one-drink-per-day limit for all adults — a stricter recommendation than current federal guidance.

Melatonin Gummies Blur Line Between Medicine and Candy

Pediatricians call for a ban on melatonin gummy bears and similar products, warning that candy-like supplements may encourage unsupervised use in children.

A New Option for Headache?

Findings come from a single-center study suggest the non-opioid suzetrigine may help reduce pain in multiple headache types, but more research is needed.

Most ‘Sleep-Divorced’ Couples Support Sleeping Separately

A study in Brazil reveals the prevalence and attitudes among couples not driven by relationship stress toward ‘sleep divorce’ arrangements.

NfL a Biomarker for Cognitive Function in Patients With MS?

New data offer strong evidence that neurofilament light chain (NfL) levels could be an accurate biomarker for monitoring cognitive function in MS.

Experimental Drug Cuts Migraine Days in Mid-stage Trial

Denmark's Lundbeck said on Thursday its experimental drug bocunebart cut monthly migraine days in ⁠a mid-stage study, supporting further development of a new type of...

Spinal Cord Treatment Triggers Hope and Lawsuits in Brazil

An experimental treatment for spinal cord injuries is drawing patients from as far as Mexico, mobilizing the government to expedite approval before its safety has been proven in a clinical trial.

Global Lewy Body Dementia Incidence: New Data

The first known analysis of pooled worldwide population-based data on dementia with Lewy bodies shows incidence is higher than that of other uncommon neurological disorders.

Comorbid Illness Common in Functional Neurologic Disorder

Functional neurologic disorder has a higher mortality rate than multiple sclerosis and often occurs with comorbid neurologic and psychiatric disorders, a new study shows.

First Clear Win for BTK Inhibitors in Relapsing MS

After previous disappointments with BTK inhibitors, a novel drug in this class is the first to show superiority to an active comparator for relapsing MS outcomes.

Primary Care Making More Mental Health Diagnoses for Kids

Pediatric mental health visits in primary care surged over a 9-year period.

Electroacupuncture Promising for Cognitive Improvement in AD

Electroacupuncture was associated with long-term efficacy in improving cognitive function compared to sham treatment in patients with Alzheimer’s disease, a new trial shows.

Coffee Linked to Better Cognition in Patients With PD

Coffee consumption is associated with improved executive function in patients with early Parkinson’s disease, while smoking has no impact, a new study suggests.

Undiagnosed Dementia Tied to Increased Mortality Risk

Undiagnosed dementia is highly prevalent in the US and Brazil and is linked to increased 4-year mortality in both countries, a large cohort study shows.

Recommended News For You

Photoacoustic spectral analysis for gaining knowledge of the tumor microenvironment.

La FDA ha approvato Talzenna per trattare il cancro alla prostata metastatico che non è resistente alla castrazione.

For MDS-Related Anemia, Telomerase Inhibitor Approved.

FDA Authorizes Three Different Uses for Injectable Antibiotic.

The standard for high-risk prostate cancer is supported by a study using high-dose RT and long-term ADT.

Discovery reveals protein involved in Parkinson's disease also drives skin cancer

An understudied type of breast cancer poses a lurking threat

Recommended Articles For You

Machine Learning for Bone Marrow Ecosystem Analysis 

Decoding Granular Cell Tumor: What You Need to Know 

Unraveling the Mysteries of Hematocrit: How It Impacts Your Health 

Beyond the Biopsy: Decoding Tumor Biology Through the Lens of Radiogenomics 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Cancer diagnosis does not spur improvements to survivors' diets or eating habits

2.

Infection Burden High With Myeloma T-Cell Therapies

3.

Capivasertib Wins Metastatic Prostate Cancer Approval

4.

Frontline Decisions in Transplant-Ineligible Multiple Myeloma: Evaluating Quadruplet Therapy

5.

Cancer Treatment Ups CV Risk; Therapy's Next Big Thing; Nude Photos Settlement

1.

Benefits of Neutrophilia: Harnessing the Power of White Blood Cells to Promote Health and Well-Being

2.

Practical Directions in Oncology in Daily Practice

3.

Neutrophil Profiling and AI Rewrites Cancer Diagnosis

4.

The Importance of Iron Rich Foods in Preventing and Treating Anemia 

5.

Emerging Insights in Hematology for Better Care

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

International Cancer Conference

4.

Asian Symposium on Advancement in Hematology and Oncology

5.

International Lung Cancer Congress®

1.

Navigating the Complexities of Ph Negative ALL - Part XV

2.

Preventing Blood Clots: The Importance of Venous Thromboembolism Management

3.

The Evolving Landscape of First-Line Treatment for Urothelial Carcinoma

4.

Summary of The Impact of CDK4/6 Inhibition in HR+/HER2- Metastatic Breast Cancer: Insights from PALOMA-2

5.

Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part IV

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot